Reading Room

Recommendations for Contraceptive Use

Previous PageNext PageTable Of Contents


NORPLANT® Implants


Q.12. What may happen if the NORPLANT® Implants are removed later than five years1?

Recommendations

Rationale

There is no risk from the NORPLANT® Implants themselves after five years. However, since the hormone levels released by NORPLANT® Implants decrease with time, after five years of use NORPLANT® Implants do not prevent pregnancy as well as during the first five years of use. Available evidence suggests that, as the rate of pregnancy increases, so will the rate of ectopic pregnancy. Because of the increased risk of pregnancy, current recommendations (which apply to all women regardless of weight or age) is that these implants be removed at the end of five years. Providers and women should be aware, however, that recent data suggest that for women who weigh less than 60 kg and/or are over 30 years of age at implant insertion, good protection still exists in years six and seven after placement, although the protection is somewhat less than that provided in the first five years. As stated above, there may be an increasing risk of intrauterine and ectopic pregnancy, but this risk tends to fall with age.

A woman may refuse to have her NORPLANT® Implants removed after five years. In such cases, the woman should be counseled on the potential risks (including pregnancy) and contraceptive benefits. If the woman still refuses to have the removal, she should be encouraged to use an additional method of contraception.

NORPLANT® Implants are a very highly effective method of protection against pregnancies for up to five years after placement. Also, in the first five years of use, the risk of ectopic pregnancy is also reduced (compared to use of no method). The blood levels of the hormone released by the implants decrease with time. Thus, it is assumed that pregnancy and ectopic pregnancy rates will both rise after five years. For these reasons, it is recommended that NORPLANT® Implants be removed after five years of use.

Recent data from a very large Chinese study clarify some of the issues. Women who weighed less than 60 kg and women over age 30 at implant insertion did not experience marked increases in pregnancy rates in years six and seven of use as compared with rates in year five, and the pregnancy rates were still quite low. A second, much smaller study in Chile found that the pregnancy rate during implant use increased to four per 100 woman years in years six through eight, but that no ectopic pregnancies occurred after the fifth year. These data perhaps suggest that although the blood levels of the drug are reduced after five years of use, this reduction is somewhat offset by the aging of the women, a factor that may principally affect women over the age of 30 who participated in the study.

Although the general recommendation to remove NORPLANT® Implants after five years pertains to all women, the Chinese and Chilean data suggest some leeway to organize and implement removal services at five years for populations where a large proportion of women weigh less than 60 kg or are over 35 years of age at the end of five years of implant use.

High priority should be placed on linking women who desire removal with providers trained with the skills necessary to perform such removals. However, if a woman does not want her NORPLANT® Implants removed, she should be informed of the risks (and contraceptive benefits) associated with use of NORPLANT® Implants beyond five years, particularly decreasing effectiveness and the possibility of ectopic pregnancy.

In additional method of contraception, and be advised about the signs and symptoms that occur with pregnancy or with ectopic pregnancy. She should further be advised to return to the clinic or facility at any time that she experiences signs or symptoms of a pregnancy or ectopic pregnancy.

  1. NORPLANT® Levonorgestrel Implants: a summary of scientific data. New York: The Population Council, 1990.
  2. Gu S, Sivin I, Du M, Zhang L, Ying L, Meng F, et al. Effectiveness of Norplant Implants through seven years: a large-scale study in China. Contraception 1995;52(2):99-103.
  3. Diaz S, Pavez M, Miranda P, Johansson ED, Croxatto HB. Long-term follow-up of women treated with Norplant Implants. Contraception 1987;35(6):551-67.
  4. Meeting Report: NORPLANT® Implants issues related to removal and quality of care. Washington, DC: USAID, June 6, 1995.

1 Currently NORPLANT® Implants are approved for only five years; however, if approval is extended beyond five years, the recommendations included here would have to be modified accordingly.


Any part of Recommendations for Updating Selected Practices in Contraceptive Use may be reproduced or adapted to meet local needs without prior permission from the TG/CWG Secretariat, provided the TG/CWG is acknowledged and the material is made available free of charge or at cost.


| Home | Family Planning | Maternal & Neonatal Health | Cervical CancerRelated Health Topics
Tools for Trainers
| Reading Room | Related Links | Search ReproLine | Website Tools

Quick Search 

Website design copyright © 1995-2003 by JHPIEGO Corporation. All rights reserved.

Last Updated: 09 Jul 2003

URL: http://www.reproline.jhu.edu/
Reproductive Health Online (ReproLine): a family planning and reproductive health training website

Top Of Page